Skip to main content

Advertisement

SpringerLink
Log in

In vitro evaluation of different protocols for the induction of mesenchymal stem cells to insulin-producing cells

  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Stem cells therapy is a new promising approach for diabetes mellitus (DM) treatment, but the insulin secretion rate in differentiated cells is low when compared with pancreas beta cells embedded in Langerhans islets. In this study, we evaluated different protocols of insulin secretion to achieve the most appropriate protocol for in vitro insulin secretion. We differentiated human umbilical cord matrix-derived mesenchymal cells (hUCMs) into insulin-producing cell (IPC) by the aim of three previously reported protocols and a modified protocol. The insulin content was analyzed through gene expression and immunocytochemistry (IHC). Dithizone (DTZ) staining was done for identification of islet-like structures. Insulin and C peptide secretion was measured by chemiluminesence immunoassay (CLIA) and enzyme immunoassay (EIA) as well. Reverse transcription-PCR (RT-PCR) showed efficient expression of insulin genes in all the study groups. IHC analysis showed higher expression of insulin and proinsulin proteins in the modified protocol. DTZ staining exhibited variable islet-like clusters in the different protocols except control. This finding was confirmed by the higher response to glucose challenge test in this group. A modified protocol using an intermediate step that makes the cells vulnerable to nestin production in combination with inducing agent results in the higher differentiation of stem cells into insulin-producing cells and more insulin secretion in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Barry FP, Murphy JM (2004) Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568–584

    Article  CAS  PubMed  Google Scholar 

  • Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49–53

    Article  CAS  PubMed  Google Scholar 

  • Carnevale G, Riccio M, Pisciotta A, Beretti F, Maraldi T, Zavatti M, Cavallini GM, La Sala GB, Ferrari A, De Pol A (2013) In vitro differentiation into insulin-producing β-cells of stem cells isolated from human amniotic fluid and dental pulp. Dig Liver Dis 45:669–676

    Article  CAS  PubMed  Google Scholar 

  • Chao KC, Chao KF, Fu YS, Liu SH (2008) Islet-like clusters derived from mesenchymal stem cells in Wharton’s jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 3:e1451

    Article  PubMed Central  PubMed  Google Scholar 

  • Chausmer AB (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109–115

    Article  CAS  PubMed  Google Scholar 

  • Chen L-B, Jiang X-B, Yang L (2004) Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10:3016–3020

    CAS  PubMed  Google Scholar 

  • Demeterco C, Beattie GM, Dib SA, Lopez AD, Hayek A (2000) A role for activin a and betacellulin in human fetal pancreatic cell differentiation and growth 1. J Clin Endocrinol Metab 85:3892–3897

    CAS  PubMed  Google Scholar 

  • Edlund H (2001) Developmental biology of the pancreas. Diabetes 50:S5

    Article  CAS  PubMed  Google Scholar 

  • Gabr MM, Sobh MM, Zakaria MM, Refaie AF, Ghoneim MA (2008) Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat diabetes in rats. Exp Clin Transplant 6:236–243

    PubMed  Google Scholar 

  • Gao R, Ustinov J, Pulkkinen M-A, Lundin K, Korsgren O, Otonkoski T (2003) Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 52:2007–2015

  • Gao F, Wu D-q, Hu Y-h, Jin G-x (2008) Extracellular matrix gel is necessary for in vitro cultivation of insulin producing cells from human umbilical cord blood derived mesenchymal stem cells. Chin Med J English Edition 121:811

    CAS  Google Scholar 

  • Hardikar AA, Marcus-Samuels B, Geras-Raaka E, Raaka BM, Gershengorn MC (2003) Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc Natl Acad Sci 100:7117–7122

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Himsworth H (2011) Diabetes mellitus: its differentiation into insulin‐sensitive and insulin‐insensitive types. Diabet Med 28:1440–1444

    Article  CAS  PubMed  Google Scholar 

  • Hori Y, Gu X, Xie X, Kim SK (2005) Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med 2:e103

    Article  PubMed Central  PubMed  Google Scholar 

  • Hunziker E, Stein M (2000) Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun 271:116–119

    Article  CAS  PubMed  Google Scholar 

  • Hussain MA, Theise ND (2004) Stem-cell therapy for diabetes mellitus. Lancet 364:203–205

    Article  PubMed  Google Scholar 

  • Jahr H, Bretzel R (2003) Insulin-positive cells in vitro generated from rat bone marrow stromal cells. Transplant Proc 35:2140–2141

    Article  CAS  PubMed  Google Scholar 

  • Javazon EH, Beggs KJ, Flake AW (2004) Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32:414–425

    Article  CAS  PubMed  Google Scholar 

  • Kaviani M, Ezzatabadipour M, Nematollahi-Mahani SN, Salehinejad P, Mohammadi M, Kalantar SM, Motamedi B (2014) Evaluation of gametogenic potential of vitrified human umbilical cord Wharton’s jelly-derived mesenchymal cells. Cytotherapy 16:203–212

    Article  CAS  PubMed  Google Scholar 

  • Kim S-J, Choi Y-S, Ko E-S, Lim S-M, Lee C-W, Kim D-I (2012) Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. J Biosci Bioeng 113:771–777

    Article  CAS  PubMed  Google Scholar 

  • Lee OK, Kuo TK, Chen W-M, Lee K-D, Hsieh S-L, Chen T-H (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669–1675

    Article  CAS  PubMed  Google Scholar 

  • Li H, Lam A, A-m X, Lam KS, Chung SK (2010) High dosage of exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells. Acta Pharmacol Sin 31:570–577

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Moshtagh PR, Emami SH, Sharifi AM (2013) Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study. J Physiol Biochem 69:451–458

    Article  CAS  PubMed  Google Scholar 

  • Nguyen PT-M, Nguyen AT-Q, Nguyen NT, Nguyen NT-M, Duong TT, Truong NH, Phan NK (2014) Human umbilical cord blood derived mesenchymal stem cells were differentiated into pancreatic endocrine cell by Pdx-1 electrotransfer. Biomed Res Therapy 1:50–56

    Google Scholar 

  • Otonkoski T, Beattie G, Mally M, Ricordi C, Hayek A (1993) Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Investig 92:1459

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Otonkoski T, Cirulli V, Beattie M, Mally MI, Soto G, Rubin JS, Hayek A (1996) A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. Endocrinology 137:3131–3139

    CAS  PubMed  Google Scholar 

  • Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, Samani FS, Torshizi Z, Nematollahi-Mahani SN (2012) Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cell Dev Biol Anim 48:75–83

    Article  PubMed  Google Scholar 

  • Serup P, Madsen OD, Mandrup-Poulsen T (2001) Islet and stem cell transplantation for treating diabetes. BMJ 322:29–32

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shiroi A, Yoshikawa M, Yokota H, Fukui H, Ishizaka S, Tatsumi K, Takahashi Y (2002) Identification of insulin‐producing cells derived from embryonic stem cells by zinc‐chelating dithizone. Stem Cells 20:284–292

    Article  CAS  PubMed  Google Scholar 

  • Sun B, Roh K-H, Lee S-R, Lee Y-S, Kang K-S (2007a) Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochem Biophys Res Commun 354:919–923

    Article  CAS  PubMed  Google Scholar 

  • Sun Y, Chen L, Hou X-g, Hou W-k, Dong J-j, Sun L, Tang K-x, Wang B, Song J, Li H (2007b) Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J Beijing-English Edition 120:771

    CAS  Google Scholar 

  • Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, Müller B, Zulewski H (2006) Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 341:1135–1140

    Article  CAS  PubMed  Google Scholar 

  • Van Phuc P, Nhung TH, Loan DTT, Chung DC, Ngoc PK (2011) Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. In Vitro Cel Dev Biol Anim 47:54–63

    Article  CAS  Google Scholar 

  • Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402–1416

    Article  CAS  PubMed  Google Scholar 

  • Wang H-S, Shyu J-F, Shen W-S, Hsu H-C, Chi T-C, Chen C-P, Huang S-W, Shyr Y-M, Tang K-T, Chen T-H (2011) Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. Cell Transplant 20:455–466

    Article  CAS  PubMed  Google Scholar 

  • Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC (2004) Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22:1330–1337

    Article  PubMed  Google Scholar 

  • Wang T, Bonner-Weir S, Oates PS, Chulak M, Simon B, Merlino G, Schmidt E, Brand S (1993) Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Investig 92:1349

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wei R, Yang J, Hou W, Liu G, Gao M, Zhang L, Wang H, Mao G, Gao H, Chen G (2013) Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm-and nestin-positive progenitor-based differentiation strategies. PLoS One 8:e72513

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wong RSY (2011) Extrinsic factors involved in the differentiation of stem cells into insulin-producing cells: an overview. Exp Diabetes Res 2011:15

    Article  Google Scholar 

  • Wu L-F, Wang N-N, Liu Y-S, Wei X (2009) Differentiation of Wharton’s jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng A 15:2865–2873

    Article  CAS  Google Scholar 

  • Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Müller B, Vallejo M, Thomas MK, Habener JF (2001) Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50:521–533

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

    Fatemeh Seyedi & Seyed Noureddin Nematollahi-Mahani

  2. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

    Fatemeh Seyedi, Mojgan Moshrefi & Seyed Noureddin Nematollahi-Mahani

  3. Afzal Research Institute, Kerman, Iran

    Fatemeh Seyedi

  4. Stem Cell Research Lab., Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

    Alireza Farsinejad

  5. Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

    Seyed Noureddin Nematollahi-Mahani

Authors
  1. Fatemeh Seyedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alireza Farsinejad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mojgan Moshrefi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyed Noureddin Nematollahi-Mahani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seyed Noureddin Nematollahi-Mahani.

Additional information

Editor: T. Okamoto

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seyedi, F., Farsinejad, A., Moshrefi, M. et al. In vitro evaluation of different protocols for the induction of mesenchymal stem cells to insulin-producing cells. In Vitro Cell.Dev.Biol.-Animal 51, 866–878 (2015). https://doi.org/10.1007/s11626-015-9890-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-015-9890-2

Keywords

Search

Navigation